Among numerous insulin preparations, basic insulin has become the first recommended initial insulin treatment plan due to its low daily injection frequency, coverage of 24 h, convenient use, and low risk of hypoglycemia [1–3]. The gene discussed is INS; the disease is Hypoglycemia.